CONTROLLED TRIAL OF CEFTAZIDIME VS TICARCILLIN AND TOBRAMYCIN IN THE TREATMENT OF ACUTE RESPIRATORY EXACERBATIONS IN PATIENTS WITH CYSTIC-FIBROSIS

被引：65
|
作者：
GOLD, R
OVERMEYER, A
KNIE, B
FLEMING, PC
LEVISON, H
机构：
[1] HOSP SICK CHILDREN,DEPT BACTERIOL,TORONTO M5G 1X8,ONTARIO,CANADA
[2] UNIV TORONTO,FAC MED,TORONTO M5S 1A1,ONTARIO,CANADA
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 1985年 / 4卷 / 02期
关键词：
D O I：
10.1097/00006454-198503000-00012
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：172 / 177
页数：6
相关论文
共 50 条
  • [21] CEFTAZIDIME IN THE TREATMENT OF CYSTIC-FIBROSIS (FC)
    MANCA, A
    MAPPA, L
    VALERIO, R
    DITERLIZZI, D
    RIGILLO, N
    NARDELLI, F
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1985, 11 (05): : 590 - 590
  • [22] PHARMACOKINETICS OF TICARCILLIN IN PATIENTS WITH CYSTIC-FIBROSIS - A CONTROLLED PROSPECTIVE-STUDY
    DEGROOT, R
    HACK, BD
    WEBER, A
    CHAFFIN, D
    RAMSEY, B
    SMITH, AL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (01) : 73 - 78
  • [23] AEROSOLIZED TOBRAMYCIN IN PATIENTS WITH CYSTIC-FIBROSIS
    ASHBY, BL
    STERN, DH
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (22): : 1659 - 1660
  • [24] PHARMACOKINETICS OF CEFTAZIDIME IN CYSTIC-FIBROSIS PATIENTS
    RAYMOND, AS
    GENILLIER, P
    LENOIR, G
    PRESSE MEDICALE, 1988, 17 (37): : 1925 - 1927
  • [25] COMPARISON OF 6 AND 8 HOURLY TOBRAMYCIN DOSING INTERVALS IN TREATMENT OF PULMONARY EXACERBATIONS IN CYSTIC-FIBROSIS PATIENTS
    WINNIE, GB
    COOPER, JA
    WITSON, J
    COWAN, RG
    MAYER, D
    LEPOW, M
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (05) : 381 - 386
  • [26] ALLERGY TO CEFTAZIDIME IN PATIENTS WITH CYSTIC-FIBROSIS
    LAVI, S
    WEBER, E
    LOZYNSKY, A
    ZIMMERMAN, B
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1985, 8 (03): : A43 - A43
  • [27] ASSESSMENT OF TOBRAMYCIN DOSING IN CYSTIC FIBROSIS PATIENTS WITH ACUTE PULMONARY EXACERBATIONS
    Thirion, D. J.
    Koloskoff, K.
    Caissy, J.
    Matouk, E.
    Marsot, A.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S177 - S178
  • [28] CEFTAZIDIME DISPOSITION IN ACUTE AND STABLE CYSTIC-FIBROSIS
    LEEDER, JS
    SPINO, M
    ISLES, AF
    TESORO, AM
    GOLD, R
    MACLEOD, SM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (03) : 355 - 362
  • [29] CIPROFLOXACIN VERSUS TOBRAMYCIN PLUS AZLOCILLIN IN PULMONARY EXACERBATIONS IN ADULT PATIENTS WITH CYSTIC-FIBROSIS
    BOSSO, JA
    BLACK, PG
    MATSEN, JM
    AMERICAN JOURNAL OF MEDICINE, 1987, 82 (4A): : 180 - 184
  • [30] AZTREONAM VS TOBRAMYCIN PLUS AZLOCILLIN IN CYSTIC-FIBROSIS
    BOSSO, JA
    BLACK, PG
    PRYKA, RD
    MATSEN, JM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 192 - 192
12345